{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:01:38Z","timestamp":1784642498346,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02696-5","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T10:32:57Z","timestamp":1779705177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SUMOylation in cancer: molecular mechanisms and therapeutic implications"],"prefix":"10.1186","volume":"25","author":[{"given":"Yu","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2696_CR1","doi-asserted-by":"publisher","first-page":"114227","DOI":"10.1016\/j.ejmech.2022.114227","volume":"233","author":"D Hua","year":"2022","unstructured":"Hua D, Wu X. Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases. Eur J Med Chem. 2022;233:114227.","journal-title":"Eur J Med Chem"},{"key":"2696_CR2","doi-asserted-by":"publisher","first-page":"122085","DOI":"10.1016\/j.lfs.2023.122085","volume":"332","author":"W Wu","year":"2023","unstructured":"Wu W, Huang C. SUMOylation and DeSUMOylation: prospective therapeutic targets in cancer. Life Sci. 2023;332:122085.","journal-title":"Life Sci"},{"issue":"8","key":"2696_CR3","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.7150\/thno.97162","volume":"14","author":"H Zhou","year":"2024","unstructured":"Zhou H, Deng N, Li Y, Hu X, Yu X, Jia S, et al. Distinctive tumorigenic significance and innovative oncology targets of SUMOylation. Theranostics. 2024;14(8):3127\u201349.","journal-title":"Theranostics"},{"issue":"1","key":"2696_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40164-023-00420-3","volume":"12","author":"Y Gu","year":"2023","unstructured":"Gu Y, Fang Y, Wu X, Xu T, Hu T, Xu Y, et al. The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications. Exp Hematol Oncol. 2023;12(1):58.","journal-title":"Exp Hematol Oncol"},{"key":"2696_CR5","doi-asserted-by":"publisher","first-page":"101401","DOI":"10.1016\/j.mam.2025.101401","volume":"106","author":"X Li","year":"2025","unstructured":"Li X, Ding R, Wang H, Chen S, Fan X, Duan Y, et al. Research advancements on sumoylation in gastrointestinal cancers. Mol Aspects Med. 2025;106:101401.","journal-title":"Mol Aspects Med"},{"key":"2696_CR6","doi-asserted-by":"publisher","first-page":"218253","DOI":"10.1016\/j.canlet.2026.218253","volume":"640","author":"Y Cao","year":"2026","unstructured":"Cao Y, Wang Y, Zhang X, Zhang Y, Zhang X, Tan X, et al. SUMOylation of SND1 drives mature miRNA degradation and tumor progression. Cancer Lett. 2026;640:218253.","journal-title":"Cancer Lett"},{"key":"2696_CR7","doi-asserted-by":"publisher","first-page":"0530","DOI":"10.34133\/research.0530","volume":"7","author":"N Tang","year":"2024","unstructured":"Tang N, Deng W, Wu Y, Deng Z, Wu X, Xiong J, et al. Single-Cell spatial-temporal analysis of ZNF451 in mediating drug resistance and CD8(+) T Cell dysfunction. Research. 2024;7:0530.","journal-title":"Research"},{"key":"2696_CR8","doi-asserted-by":"publisher","first-page":"1654167","DOI":"10.3389\/fimmu.2025.1654167","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu X, Ding W, Jiang L, Chen Q, Luo X. Unraveling the critical role of SUMOylation in the governing of tumor immunity. Front Immunol. 2025;16:1654167.","journal-title":"Front Immunol"},{"issue":"1","key":"2696_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12929-025-01202-1","volume":"33","author":"HC Hsieh","year":"2026","unstructured":"Hsieh HC, Ling LL, Wang YC. Post-translational modifications of immune checkpoints: molecular mechanisms, tumor microenvironment remodeling, and therapeutic implications. J Biomed Sci. 2026;33(1):3.","journal-title":"J Biomed Sci"},{"key":"2696_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202511449","author":"UM Demel","year":"2026","unstructured":"Demel UM, Meurer A, Zaghla BKQ, Atay B, Steiert D, Hummel LV, et al. Aberrant SUMOylation restricts the targetable cancer immunopeptidome. Adv Sci. 2026. https:\/\/doi.org\/10.1002\/advs.202511449.","journal-title":"Adv Sci"},{"key":"2696_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152383","author":"UM Demel","year":"2022","unstructured":"Demel UM, B\u00f6ger M, Yousefian S, Grunert C, Zhang L, Hotz PW, et al. Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI152383.","journal-title":"J Clin Invest"},{"key":"2696_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf750","author":"A Goffeney","year":"2025","unstructured":"Goffeney A, Hendriks IA, Morel V, Loe-Mie Y, Charon F, Nielsen ML, et al. SUMO operates from a unique long tandem repeat to keep innate immunity in check. Nucleic Acids Res. 2025. https:\/\/doi.org\/10.1093\/nar\/gkaf750.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2696_CR13","first-page":"1040","volume":"22","author":"V Lam","year":"2023","unstructured":"Lam V, Roleder C, Liu T, Bruss N, Best S, Wang X, et al. T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor. Chronic Lymphocytic Leukemia Mol Cancer Ther. 2023;22(9):1040\u201351.","journal-title":"Chronic Lymphocytic Leukemia Mol Cancer Ther"},{"key":"2696_CR14","doi-asserted-by":"publisher","first-page":"1686880","DOI":"10.3389\/fimmu.2025.1686880","volume":"16","author":"S Padmakumar","year":"2025","unstructured":"Padmakumar S, Madhavan A, Nair BG, Kumar GB. Pathogen-induced hijacking of host SUMOylation: from molecular mechanisms and prospects for therapeutic modulation. Front Immunol. 2025;16:1686880.","journal-title":"Front Immunol"},{"issue":"8","key":"2696_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41577-025-01155-4","volume":"25","author":"MDN Tharuka","year":"2025","unstructured":"Tharuka MDN, Courelli AS, Chen Y. Immune regulation by the SUMO family. Nat Rev Immunol. 2025;25(8):608\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2696_CR16","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1158\/1535-7163.MCT-23-0572","volume":"23","author":"S Erdem","year":"2024","unstructured":"Erdem S, Lee HJ, Shankara Narayanan JSN, Tharuka MDN, De la Torre J, Ren T, et al. Inhibition of SUMOylation induces adaptive antitumor immunity against pancreatic cancer through multiple effects on the tumor microenvironment. Mol Cancer Ther. 2024;23(11):1597\u2013612.","journal-title":"Mol Cancer Ther"},{"issue":"611","key":"2696_CR17","doi-asserted-by":"publisher","first-page":"eaba7791","DOI":"10.1126\/scitranslmed.aba7791","volume":"13","author":"ES Lightcap","year":"2021","unstructured":"Lightcap ES, Yu P, Grossman S, Song K, Khattar M, Xega K, et al. A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models. Sci Transl Med. 2021;13(611):eaba7791.","journal-title":"Sci Transl Med"},{"issue":"11","key":"2696_CR18","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1136\/gutjnl-2021-324834","volume":"71","author":"S Kumar","year":"2022","unstructured":"Kumar S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, Sluijter M, Ruano D, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model. Gut. 2022;71(11):2266\u201383.","journal-title":"Gut"},{"issue":"1","key":"2696_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41392-023-01450-3","volume":"8","author":"X Ma","year":"2023","unstructured":"Ma X, Jia S, Wang G, Liang M, Guo T, Du H, et al. TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal Transduct Target Ther. 2023;8(1):246.","journal-title":"Signal Transduct Target Ther"},{"key":"2696_CR20","doi-asserted-by":"publisher","first-page":"1424393","DOI":"10.3389\/fimmu.2024.1424393","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Sun C, Liu M, Xu P, Li Y, Zhang Y, et al. Dysregulated gene expression of SUMO machinery components induces the resistance to anti-PD-1 immunotherapy in lung cancer by upregulating the death of peripheral blood lymphocytes. Front Immunol. 2024;15:1424393.","journal-title":"Front Immunol"},{"key":"2696_CR21","doi-asserted-by":"publisher","unstructured":"De la Torre Medina J, Joshi U, Sonowal H, Kuang Y, Ren T, Chen DH, et al. Immunomodulation of pancreatic cancer via inhibition of SUMOylation and CD155\/TIGIT Pathway. Mol Cancer Ther. 2025. https:\/\/doi.org\/10.1158\/1535-7163.MCT-25-0129.","DOI":"10.1158\/1535-7163.MCT-25-0129"},{"issue":"2","key":"2696_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41418-022-01097-7","volume":"30","author":"K Gao","year":"2023","unstructured":"Gao K, Shi Q, Gu Y, Yang W, He Y, Lv Z, et al. SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis. Cell Death Differ. 2023;30(2):475\u201387.","journal-title":"Cell Death Differ"},{"issue":"31","key":"2696_CR23","doi-asserted-by":"publisher","first-page":"8360","DOI":"10.1039\/D3SC02140H","volume":"14","author":"Y Qin","year":"2023","unstructured":"Qin Y, Zhang X, Song Y, Zhong B, Liu L, Wang D, et al. A highly sensitive nanochannel device for the detection of SUMO1 peptides. Chem Sci. 2023;14(31):8360\u20138.","journal-title":"Chem Sci"},{"issue":"2","key":"2696_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s13402-023-00880-z","volume":"47","author":"Z Wang","year":"2024","unstructured":"Wang Z, Pan B, Su L, Yu H, Wu X, Yao Y, et al. SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma. Cell Oncol (Dordr). 2024;47(2):513\u201332.","journal-title":"Cell Oncol (Dordr)"},{"key":"2696_CR25","doi-asserted-by":"publisher","first-page":"1577781","DOI":"10.3389\/fimmu.2025.1577781","volume":"16","author":"Z Deng","year":"2025","unstructured":"Deng Z, Xu Y, Zhang P, Peng Y, Tan J, Chen Z, et al. Integrated machine learning and single-cell analysis reveal the prognostic and therapeutic potential of SUMOylation-related genes in ovarian cancer. Front Immunol. 2025;16:1577781.","journal-title":"Front Immunol"},{"key":"2696_CR26","doi-asserted-by":"publisher","first-page":"1675874","DOI":"10.3389\/fimmu.2025.1675874","volume":"16","author":"W He","year":"2025","unstructured":"He W, Sun Z, Li D, Yu T. Significance of SUMOylation in breast cancer progression: a comprehensive investigation using single-cell analysis and bioinformatics. Front Immunol. 2025;16:1675874.","journal-title":"Front Immunol"},{"issue":"6","key":"2696_CR27","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/HEP.0000000000001259","volume":"82","author":"P Olaizola","year":"2025","unstructured":"Olaizola P, Olaizola I, Fernandez de Ara M, Lapitz A, Val B, Izquierdo-Sanchez L, et al. Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk. Hepatology. 2025;82(6):1461\u201379.","journal-title":"Hepatology"},{"key":"2696_CR28","doi-asserted-by":"publisher","first-page":"1200939","DOI":"10.3389\/fimmu.2023.1200939","volume":"14","author":"A Youssef","year":"2023","unstructured":"Youssef A, Mohammed BK, Prasad A, Del Aguila A, Bassi G, Yang W, et al. Splenic SUMO1 controls systemic inflammation in experimental sepsis. Front Immunol. 2023;14:1200939.","journal-title":"Front Immunol"},{"issue":"2","key":"2696_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ymthe.2025.10.052","volume":"34","author":"J Cai","year":"2026","unstructured":"Cai J, Pan J, Zeng Y, Wei J, Yi M, Xiang Y, et al. SUMOylation protects against sepsis-associated acute kidney injury by stabilizing IkappaBalpha. Mol Ther. 2026;34(2):1277\u201391.","journal-title":"Mol Ther"},{"key":"2696_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells14030235","author":"F Imbert","year":"2025","unstructured":"Imbert F, Langford D. Comprehensive SUMO proteomic analyses identify HIV latency-associated proteins in Microglia. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14030235.","journal-title":"Cells"},{"issue":"1","key":"2696_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41420-026-02946-x","volume":"12","author":"J Qian","year":"2026","unstructured":"Qian J, Yu L, Tian M, Li X, Bai X, Yang J, et al. SUMOylation is destined for regulatory T cell-related immune dysregulation. Cell Death Discov. 2026;12(1):90.","journal-title":"Cell Death Discov"},{"issue":"8","key":"2696_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.trecan.2023.04.010","volume":"9","author":"Y Chen","year":"2023","unstructured":"Chen Y. A new immuno-oncology target - SUMOylation. Trends Cancer. 2023;9(8):606\u20138.","journal-title":"Trends Cancer"},{"issue":"1","key":"2696_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/1040841X.2024.2339259","volume":"51","author":"G Zhu","year":"2025","unstructured":"Zhu G, Tong N, Zhu Y, Wang L, Wang Q. The crosstalk between SUMOylation and immune system in host-pathogen interactions. Crit Rev Microbiol. 2025;51(1):164\u201386.","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"2696_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12935-024-03323-3","volume":"24","author":"X Li","year":"2024","unstructured":"Li X, Ding Z, Tong Y. Identification of SUMOylation-related biomarkers in papillary thyroid carcinoma. Cancer Cell Int. 2024;24(1):149.","journal-title":"Cancer Cell Int"},{"key":"2696_CR35","doi-asserted-by":"publisher","first-page":"864156","DOI":"10.3389\/fimmu.2022.864156","volume":"13","author":"QD Xia","year":"2022","unstructured":"Xia QD, Sun JX, Xun Y, Xiao J, Liu CQ, Xu JZ, et al. SUMOylation pattern predicts prognosis and indicates tumor microenvironment infiltration characterization in bladder cancer. Front Immunol. 2022;13:864156.","journal-title":"Front Immunol"},{"issue":"11","key":"2696_CR36","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1158\/2767-9764.CRC-25-0243","volume":"5","author":"D Juric","year":"2025","unstructured":"Juric D, Anderson D, Dowlati A, Rodon J, Lugowska I, Ma\u0144dziuk S, et al. A first-in-human study of the sumoylation inhibitor subasumstat in patients with advanced\/metastatic solid tumors or relapsed\/refractory hematologic malignancies. Cancer Res Commun. 2025;5(11):2025\u201338.","journal-title":"Cancer Res Commun"},{"key":"2696_CR37","doi-asserted-by":"publisher","first-page":"111798","DOI":"10.1016\/j.biopha.2021.111798","volume":"141","author":"X Hao","year":"2021","unstructured":"Hao X, Ren Y, Feng M, Wang Q, Wang Y. Metabolic reprogramming due to hypoxia in pancreatic cancer: implications for tumor formation, immunity, and more. Biomed Pharmacother. 2021;141:111798.","journal-title":"Biomed Pharmacother"},{"issue":"Pt 2","key":"2696_CR38","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.semcancer.2022.03.026","volume":"86","author":"V Gowd","year":"2022","unstructured":"Gowd V, Ahmad A, Tarique M, Suhail M, Zughaibi TA, Tabrez S, et al. Advancement of cancer immunotherapy using nanoparticles-based nanomedicine. Semin Cancer Biol. 2022;86(Pt 2):624\u201344.","journal-title":"Semin Cancer Biol"},{"issue":"19","key":"2696_CR39","doi-asserted-by":"publisher","first-page":"e2417920","DOI":"10.1002\/adma.202417920","volume":"37","author":"Y Wang","year":"2025","unstructured":"Wang Y, Dong A, Man J, Chen H, Shen W, Wang L, et al. TREM2 scFv-engineering escherichia coli displaying modulation of macrophages to boost cancer radio-immunotherapy. Adv Mater. 2025;37(19):e2417920.","journal-title":"Adv Mater"},{"issue":"3","key":"2696_CR40","doi-asserted-by":"publisher","first-page":"102620","DOI":"10.1016\/j.omtn.2025.102620","volume":"36","author":"G Zhang","year":"2025","unstructured":"Zhang G, Tu J, Zhang Y, He J, Peng G, Fan Q, et al. Nanoparticle delivery of VEGF-B mRNA promotes T cell infiltration within tumor and triggers robust antitumor immunity. Mol Ther Nucleic Acids. 2025;36(3):102620.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2696_CR41","doi-asserted-by":"publisher","first-page":"1614640","DOI":"10.3389\/fimmu.2025.1614640","volume":"16","author":"H Piao","year":"2025","unstructured":"Piao H, Jiang Y, Jin S, Shi J, Yu J, Wang W, et al. Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy. Front Immunol. 2025;16:1614640.","journal-title":"Front Immunol"},{"issue":"18","key":"2696_CR42","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1158\/0008-5472.CAN-21-0468","volume":"81","author":"X Qiu","year":"2021","unstructured":"Qiu X, Yang S, Wang S, Wu J, Zheng B, Wang K, et al. M(6)A Demethylase ALKBH5 Regulates PD-L1 expression and tumor immunoenvironment in intrahepatic cholangiocarcinoma. Cancer Res. 2021;81(18):4778\u201393.","journal-title":"Cancer Res"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02696-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:05:58Z","timestamp":1784639158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02696-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2696"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02696-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not available.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":2,"name":"Ethics","label":"Consent for publications","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"180"}}